4503 Astellas Pharma Inc. - Historical Price

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Date	Opening	High	Low	Closing Price	Change	%	Volume
Dec, 2024	1,570	1,624	1,501	1,519	-43	-2.72%	88,424,200

Monthly Price

Date	Opening	High	Low	Closing Price	Change	%	Volume
Nov, 2024	1,769.5	1,796.5	1,544.0	1,561.5	-234.0	-13.03%	124,315,800
Oct, 2024	1,650.0	1,810.5	1,645.5	1,795.5	+148.5	+9.02%	107,967,200
Sep, 2024	1,820.0	1,824.5	1,621.0	1,647.0	-170.0	-9.36%	122,021,200
Aug, 2024	1,736.5	1,835.0	1,584.0	1,817.0	+69.5	+3.98%	175,413,300
Jul, 2024	1,590.5	1,749.0	1,567.0	1,747.5	+157.5	+9.91%	139,557,800
Jun, 2024	1,562.5	1,614.0	1,482.0	1,590.0	+41.5	+2.68%	135,838,100
May, 2024	1,513.5	1,585.0	1,481.0	1,548.5	+34.5	+2.28%	149,349,100
Apr, 2024	1,652.0	1,671.0	1,426.0	1,514.0	-129.5	-7.88%	196,924,700
Mar, 2024	1,656.0	1,696.5	1,551.0	1,643.5	-8.0	-0.48%	188,410,100
Feb, 2024	1,705.0	1,712.5	1,591.0	1,651.5	-73.5	-4.26%	180,859,600
Jan, 2024	1,716.5	1,801.5	1,676.0	1,725.0	+39.0	+2.31%	147,132,300
Dec, 2023	1,810.0	1,814.0	1,600.5	1,686.0	-111.5	-6.20%	143,610,100
Nov, 2023	1,955.0	1,955.0	1,748.0	1,797.5	-102.5	-5.39%	197,730,700
Oct, 2023	2,084.0	2,112.5	1,865.0	1,900.0	-174.0	-8.39%	159,923,600
Sep, 2023	2,193.5	2,241.0	2,066.5	2,074.0	-140.5	-6.34%	121,312,700
Aug, 2023	2,095.0	2,270.0	1,976.5	2,214.5	+134.0	+6.44%	159,546,800
Jul, 2023	2,158.5	2,161.5	1,983.0	2,080.5	-68.5	-3.19%	115,903,400
Jun, 2023	2,220.0	2,312.5	2,131.0	2,149.0	-58.5	-2.65%	117,405,800
May, 2023	2,030.0	2,360.5	2,030.0	2,207.5	+159.5	+7.79%	121,423,400
Apr, 2023	1,885.0	2,052.5	1,877.0	2,048.0	+165.0	+8.76%	91,753,800

Astellas Pharma Inc.(4503) Historical

Latest Monthly Price

Monthly Price